Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Instillation in Acute Complex Appendicitis
NCT05470517Phase 2Completed
- Sponsor
- Johns Hopkins All Children's Hospital
- Start
- Jan 2023
- Primary completion
- Feb 2024
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of ceftriaxone in appendicitis (2 arms), sponsored by Johns Hopkins All Children's Hospital. Primary endpoints: Feasibility of the Use of Antibiotic Solution Instillation Following Intraoperative Diagnosis of Complex Appendicitis as Assessed by Percentage of Eligible Participants Who Agree to Participate, Feasibility of the Use of Antibiotic Solution Instillation Following Intraoperative Diagnosis of Complex Appendicitis as Assessed by Percentage of Randomized Participants Who Complete All… and 1 more. Started Jan 2023; status: completed.
02
Drugs
ceftriaxone
03
Conditions
appendicitis
Beyond the preview
Go deeper on NCT05470517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05470517.